Home Newsfeeds Loop Capital Initiates Coverage On Applied Materials with Buy Rating, Announces Price Target of $125

Loop Capital Initiates Coverage On Applied Materials with Buy Rating, Announces Price Target of $125

Loop Capital analyst Scott Graham initiates coverage on Applied Materials (NASDAQ:AMAT) with a Buy rating and announces Price Target of $125.

byBenzinga Newsdesk

December 7, 2022

1 minute read

Loop Capital analyst Scott Graham initiates coverage on Applied Materials (NASDAQ:AMAT) with a Buy rating and announces Price Target of $125.

AngioDynamics Announces Sale Of Dialysis Product Portfolio And BioSentry Product To Merit Medical Systems For $100M; Announces Preliminary FY23 Net Sales In The Range Of $338M-$339M Vs $338.83M Est.

By Happy Mohamed

June 8, 4:03 PM

Announces preliminary Fiscal Year 2023 net sales in the range of $338 million to $339 million AngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative medical technology company focused on

ANGO

Cyxtera Technologies Q2 EPS $(0.27) Misses $(0.20) Estimate, Sales $184.10M Up From $175.40M YoY

By Benzinga Newsdesk

August 11, 7:12 AM

Cyxtera Technologies (NASDAQ:CYXT) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.20) by 35 percent. The company reported $184.10 million in sales this quarter. This is

CYXT

Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical’s $1.3B Deal

By Vandana Singh

June 18, 10:02 AM

Boston Scientific to acquire Silk Road Medical for $1.26 billion, enhancing its vascular portfolio with Silk Road's TCAR system, a breakthrough in stroke prevention. Transaction closes in H2 2024.

BSX

Gold Bull Peter Schiff Warns This Will Send Economy ‘Deeper Into Recession’ After Weak Jobs Data: ‘That’s Real Bidenomics’

By Shanthi Rexaline

August 31, 5:02 AM

Peter Schiff warned a deeper recession could be in the cards following a slew of weak data that point to a potential dollar weakness.

TIP

Loop Capital Initiates Coverage On Applied Materials with Buy Rating, Announces Price Target of $125

Related Posts

AngioDynamics Announces Sale Of Dialysis Product Portfolio And BioSentry Product To Merit Medical Systems For $100M; Announces Preliminary FY23 Net Sales In The Range Of $338M-$339M Vs $338.83M Est.

Cyxtera Technologies Q2 EPS $(0.27) Misses $(0.20) Estimate, Sales $184.10M Up From $175.40M YoY

Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical’s $1.3B Deal

Gold Bull Peter Schiff Warns This Will Send Economy ‘Deeper Into Recession’ After Weak Jobs Data: ‘That’s Real Bidenomics’